Vismata transforms raw genomic data into profound biological insights — powering precision medicine, biomarker discovery, and next-generation biotech through unparalleled analysis depth and accuracy.
Decode the genome at scale with rigorous, innovative analysis — unlocking earlier diagnoses, smarter therapies, and faster scientific progress.
Advanced NGS pipelines, variant calling, functional annotation, multi-omics fusion, and custom algorithms built for high-stakes genomic interpretation.
Santa Clara-based genomic analysts, computational biologists, and biotech pioneers committed to turning DNA sequences into life-changing knowledge.
High-sensitivity calling of SNPs, indels, SVs, and CNVs with layered annotation, pathogenicity scoring, and clinical relevance filtering.
Individual genome profiling for oncology targets, rare variant discovery, pharmacogenomic guidance, and risk stratification.
Genome-wide association, differential analysis, and machine-learning driven signature identification from large-scale cohorts.
Integrating WGS/WES with RNA-seq, epigenomics, and proteomics to reveal regulatory networks and disease mechanisms.
Full end-to-end: quality control, alignment, variant calling, annotation, prioritization, and interactive reporting.
Tailored workflows — long-read, single-cell, metagenomic, transcriptomic differential expression, pathway/network analysis.
Somatic/germline paired analysis, tumor heterogeneity, fusion detection, hereditary panels, and therapeutic matching.
Study design, data strategy, interpretation support, and collaborative R&D for biotech, pharma, and research institutions.